Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. It utilizes its expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, which the company refers to as the Kinnate Discovery Engine, to develop targeted therapies.